Michael A. Metzger

Companies

• Pyxis Oncology, Inc.Board member Jun 10, 2024 to now¹
• Syndax Pharmaceuticals IncChief executive officer Feb 3, 2022 to now²
• Syndax Pharmaceuticals IncBoard member Jul 8, 2019 to now³
• CTI BioPharmaBoard member Jan 24, 2017 to Jun 26, 2023⁴
• Syndax Pharmaceuticals IncChief operating officer Mar 2, 2016 to Dec 20, 2021⁵
• Syndax Pharmaceuticals IncPresident Mar 2, 2016 to Dec 20, 2021⁵

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• SPSyndax Pharmaceuticals Inc SNDX484,843 shares⁶$6.3M at $13.05Jul 8, 2026
• CTI BioPharma0 shares⁷Nov 8, 2022

As of each latest filing. The line shows shares held over time.

Recent filings

• Jul 8, 2026Sold 32,375 shares at $24.24 of Syndax Pharmaceuticals Inc⁶
• Jul 8, 2026Exercised options 32,375 shares at $6.38 of Syndax Pharmaceuticals Inc⁶
• Jun 1, 2026Sold 6,847 shares at $18.99 of Syndax Pharmaceuticals Inc⁸
• Feb 9, 2026Sold 17,159 shares at $21.03 of Syndax Pharmaceuticals Inc⁹
• Feb 6, 2026Sold 7,412 shares at $20.62 of Syndax Pharmaceuticals Inc¹⁰
• Feb 4, 2026Granted 144,600 shares of Syndax Pharmaceuticals Inc¹⁰
• Feb 4, 2026Granted 73,000 shares of Syndax Pharmaceuticals Inc¹⁰
• Sep 8, 2025Sold 157,307 shares at $16.41 of Syndax Pharmaceuticals Inc¹¹
• Sep 8, 2025Exercised options 157,307 shares at $10.90 of Syndax Pharmaceuticals Inc¹¹
• Jul 16, 2025Sold 7,534 shares at $9.29 of Syndax Pharmaceuticals Inc¹²
• Mar 14, 2025Exercised options 6,074 shares at $7.20 of Syndax Pharmaceuticals Inc¹³
• Mar 4, 2025Sold 7,814 shares at $15.05 of Syndax Pharmaceuticals Inc¹⁴
• Mar 4, 2025Exercised options 7,814 shares at $7.20 of Syndax Pharmaceuticals Inc¹⁴
• Feb 10, 2025Sold 13,288 shares at $15.50 of Syndax Pharmaceuticals Inc¹⁵
• Feb 5, 2025Granted 89,000 shares of Syndax Pharmaceuticals Inc¹⁶
• Feb 5, 2025Granted 60,500 shares of Syndax Pharmaceuticals Inc¹⁶
• Feb 7, 2024Granted 39,000 shares of Syndax Pharmaceuticals Inc¹⁷
• Feb 7, 2024Granted 107,250 shares of Syndax Pharmaceuticals Inc¹⁷
• Feb 6, 2023Sold 5,959 shares at $27.64 of Syndax Pharmaceuticals Inc¹⁸
• Feb 6, 2023Exercised options 5,959 shares at $6.38 of Syndax Pharmaceuticals Inc¹⁸
• Nov 8, 2022Sold 4,500 shares at $5.70 of CTI BioPharma⁷
• Nov 8, 2022Sold 36,942 shares at $5.65 of CTI BioPharma⁷
• Nov 8, 2022Sold 50,058 shares at $5.53 of CTI BioPharma⁷
• Nov 8, 2022Exercised options 63,000 shares at $1.00 of CTI BioPharma⁷
• Nov 8, 2022Exercised options 28,500 shares at $0.84 of CTI BioPharma⁷